Global Tumor Ablation Devices Market - Trends and Forecast to 2025
With the robust development of imaging devices and modalities during past two decades, image guided techniques like tumor ablation has become a powerful tool for definitive treatment of certain benign and malignant tumors of the lungs, liver, kidneys, bone, and soft tissues and for pain palliation. Tumor ablation is one of the minimally invasive procedure used to destroy cancer cells in the chest, lung and liver and other areas of patients’ body. The change in lifestyle and unhealthy eating habits, along with increasing consumption of tobacco and alcohol is the leading cause for growth in number of cancer cases. As per stats released by National Cancer Institute (NCI), around 1,685,210 new cases of cancer were diagnosed in the U.S. in 2016.
The global tumor ablation devices market is valued at US$ 464.18 million in 2017 and is expected to witness a CAGR of 10.2% over the forecast period (2017 – 2025).
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/1270
New product launches by manufacturers is a prominent factor fueling market growth
Increasing prevalence of various cancer globally rising the demand of treatment through ablation procedure due to its lesser/minimal side effect rates over other procedures intended to boost the tumor ablation devices market. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality across the world, with approximately 14 million new cases reported worldwide in 2012.
Tumor Ablation devices market is focused towards the benign tumors and early forms of malignant tumors treatment that can be removed with the help of minimally invasive surgical methods. According to the World Health Organization (WHO) data 2012, 30-50% deaths caused due to cancer can be prevented by adequate treatment in early stages and can drastically reduce risk factors. Companies in tumor ablation devices market are focusing towards enhancing its strength through new product launches within shorter product approval time than required, merger & acquisition to enhance their product portfolio and increase the visibility of the market over the forecast period.
For instance, in 2016, Ethicon (A Johnson & Johnson (J&J) company) acquired NeuWave Medical Inc., a medical device company, which manufactures and markets minimally invasive soft tissue microwave ablation systems. These acquisition will help J&J to expand its product portfolio in the ablation devices market. On the contrary, the high costs associated with the devices mainly cryoablation devices are usually unaffordable to middle class and low income population. This high cost incurred with these devices acts as a hindrance for the global market growth. However, these devices has few advantages over open surgeries. Firstly, the cost incurred by these surgical procedures are relatively less than that open surgical procedures. Secondly, these devices are of great convenience when it comes to pain reduction, accuracy and efficiency.
Emerging economies to fuel the market growth
On the basis of regional segmentation, the global tumor ablation devices market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account for the largest share followed by Europe and Asia Pacific. Tumor ablation devices market in North America is driven by factors, such as trend of replacing older technologies and introducing the new technologies, and increase in private and public funding to develop and commercialize the novel tumor ablation products. For instance, in 2016, EDAP TMS has made high-intensity focused ultrasound (HIFU) systems, robotic device that allows for the safe ablation of prostate tissue, available in the prestigious institutions such as USC in Los Angeles, University of Miami, Duke University, the Cleveland Clinic, thus building awareness, allowing global adoption of the technology with rapid U.S. market penetration.
Click here to know more about this publish report: https://www.coherentmarketinsights.com/market-insight/tumor-ablation-devices-market-1270
The market is also expected to gain significant traction in emerging economies of Asia Pacific, due to projected spurt in number of cancer cases detected in the region and the implementation of government initiatives to build healthcare infrastructure. For instance, the government of China in 2016 had spent around US$ 371 billion on healthcare reforms and US$ 100 billion in providing insurance to the citizens, improving the infrastructure of public hospitals and community healthcare facilities. The growing awareness of diagnostic procedures and treatment options for certain cancers has created tremendous opportunities for the growth of vendors in the market.
The key players operating in the global market of tumor ablation devices include Boston Scientific Corporation, Medtronic Plc, Intuitive Surgical, Inc., Johnson & Johnson, Smith & Nephew Plc., Angiodynamics, HealthTronics, Inc, SonaCare Medical, LLC., Galil Medical Inc., EDAP TMS S.A., Abbott Laboratories, NuVasive, Inc, Alpinion Medical Systems Co., Ltd.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Visit our news Website: http://www.coherentchronicle.com/
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Tumor Ablation Devices Market - Trends and Forecast to 2025 here
News-ID: 937711 • Views: 223
More Releases from Medical Devices Market
Needles Market to Reach US$ 8.3 Billion by 2025
Growing geriatric population worldwide to drive growth of the global needles market Rising geriatric population is expected to drive growth of the needles market. As per World Population Prospect, 2017 Revision report by United Nations in 2017, there were 962 million people, under the geriatric category (people aged 60 years and above). By 2030, this is projected to be 1.4 billion increasing at an annual rate of 3%. Geriatric people require
X Ray Detectors Market -
X-ray technology is the most conventional and widely used form of medical imaging. X-rays consist of ionizing radiations, which are passed through the patient’s body and are absorbed by the internal organs. X-rays have been in use for non-invasive imaging of biological matters by passing high resolution radiations. X-Rays have wide range of applications such as structural imaging of bones, cavities in soft tissues, and metal implants pre and post
Blood Collection Devices Market - Global Industry Insights, 2025
Blood collection devices plays a crucial role in the patient treatment. For the treatment, blood samples are collected to measure the basic metabolism components such as blood urea nitrogen, sodium, potassium, creatinine, magnesium, chloride, and also used to measure blood glucose and lipid levels. In the recent years, as technology has increased in availability and complexity, the experts in the laboratories are receiving wide range of opportunities and challenges. In
Research of Medical Devices Market with Focus on Korea in Global Industry : Shar …
Albany, NY, 3rd November : Recent research and the current scenario as well as future market potential of "Global Medical Devices Market with Focus on Korea: Industry Analysis & Outlook (2017-2021)" globally. Medical device is an instrument, implant, contrivance or a machine used in prevention, diagnosis and treatment of illness, or detecting, restoring or modifying the structure or function of the body for health purpose. Medical devices come with numerous varieties,
More Releases for Tumor
Global Tumor Ablation Market Outlook To 2026
Global Tumor Ablation Market Outlook To 2026: In-Depth Market Overview, Key Treatment Type (Surgical, Percutaneous), Technology (Cryoablation, IRE, MWA, RFA), Application Categories (Liver, Lung, Breast, Prostate), Regional Segmentation, Pricing Analysis, Pipeline Analysis, Competitive Dynamics, M&A Insights, Segment Forecast And Conclusion The Tumor Ablation Market was valued at $1.08Billion in 2018 and is forecast to grow at a modest12.2% CAGR between2018 and 2025, culminating in 2026 global sales of $4.2Billion. Tumor Ablation
Global Tumor Ablation Devices Market - Insights
Increasing prevalence of various cancer globally rising the demand of treatment through ablation procedure due to its lesser/minimal side effect rates over other procedures intended to boost the tumor ablation devices market. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality across the world, with approximately 14 million new cases reported worldwide in 2012. Click To Continue Reading: https://www.coherentmarketinsights.com/market-insight/tumor-ablation-devices-market-1270 Tumor Ablation devices market
Global Tumor Ablation Devices Market - Insights
Rising prevalence of tumor cases is the major factor that contributes in the growth of the tumor ablation devices market. According the Central Brain Tumor Registry of the US (CBTRUS), 2015, there are over 138,000 people in the US living with primary brain and central nervous system malignant tumors. Various key players are involved in sustainable development of minimally invasive ablation devices for various types such as catheter ablation, cryoablators,
Tumor Ablation Market: Industry Evolution/Development
A recent study by Transparency Market Research (TMR) has detected that the competition in the global tumor ablation market is intense, in a fragmented scenario with the presence of a number of participants. That being said, there are plenty of growth opportunities too in the market for tumor ablation, which will continue to attract pharmaceutical companies and further intensify the competition. The TMR report projects the global tumor ablation market
Tumor Necrosis Factor Receptor
WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Tumor Necrosis Factor - Pipeline Review, H2 2017” Tumor Necrosis Factor Overview Tumor Necrosis Factor Receptor Superfamily Member 18 (Glucocorticoid Induced Tumor Necrosis Factor Receptor or Activation Inducible TNFR Family Receptor or Glucocorticoid Induced TNFR Related Protein or CD357 or TNFRSF18) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed
Personalised tumor vaccines keep cancer in check
Throughout the last decade, novel cancer therapeutics has seen tremendous developments, through targeting tumor cell-intrinsic pathways, as well as targeting tumor cell-extrinsic factors such as growth factors. Notable clinical success of checkpoint inhibitors as well as adoptively transferred genetically engineered T cells further demonstrates the critical role of T-cells in cancer control and rejection. However, many patients still do not respond to checkpoint inhibitor therapies. This creates the need for